Literature DB >> 111939

Serum kinetics of doxycycline polyphosphate in dogs.

G Michel, J Mosser, F Fauran.   

Abstract

Serum kinetics of Doxycycline polyphosphate (DPP) have been studied in dogs after oral administration of 10 mg.kg-1 by measurement of total serum concentration (Ct) of tetracycline derivatives by a chemical assay and active concentration (Ca) by a microbiological method. Kinetics have been studied using a one compartment open model with absorption by oral route. DPP is rapidly absorbed, the peak serum level is reached three hours after absorption and slowly eliminated (elimination half-life = 12 hours). The main differences observed between Ct and Ca kinetics are in the values of the areas under the curves (AUC) and the peak serum level. The values obtained for these parameters for Ca kinetics were found to be 50% of those obtained for Ct, the volumes of distribution being in inverse proportion. These results are in a good agreement with the correlation and linear regression observed between Ca and Ct showing that 55% of total serum Doxycycline possesses immediate antibacterial activity. It is postulated that this difference between Ct and Ca kinetics is essentially a reflection of the ratios of bound and free drug. Similar results were obtained with the finished pharmaceutical form except for a 15% increase of AUC indicating improvement of the bioavailability of the drug.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111939     DOI: 10.1007/BF03189398

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  16 in total

1.  Estimation of the degree of binding of tetracyclines in human plasma.

Authors:  R G Green; J R Brown; R T Calvert
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

2.  [Importance of 2d generation tetracyclines. Pharmacokinetic behavior].

Authors:  J B Fourtillan; M C Saux
Journal:  Sem Hop       Date:  1978-02

Review 3.  [Antibiotics and protein binding].

Authors:  J P Tillement; L Chauvelot
Journal:  Therapie       Date:  1978 May-Jun       Impact factor: 2.070

4.  Influence of repetitive dosing and altered urinary pH on doxycycline excretion in humans.

Authors:  J M Jaffe; R I Poust; S L Feld; J L Colaizzi
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

6.  [Doxycycline. Absorption, distribution and excretion of a new broad spectrum antibiotic in man].

Authors:  J Fabre; J S Pitton; C Virieux; F L Laurencet; J P Bernhardt; J C Godel
Journal:  Schweiz Med Wochenschr       Date:  1967-07-15

7.  Comparative bioavailability of doxycycline.

Authors:  J D Arcilla; J L Fiore; O Resnick; J W Nadelmann; J L Huth; W M Troetel
Journal:  Curr Ther Res Clin Exp       Date:  1974-10

8.  Use of computers in pharmacokinetics.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1967 Jan-Feb       Impact factor: 6.875

9.  The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.

Authors:  W A Mahon; G E Johnson; L Endrenyl; M F Kelly; S S Fenton
Journal:  Scand J Infect Dis Suppl       Date:  1976

10.  Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects.

Authors:  P G Welling; P A Koch; C C Lau; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

View more
  7 in total

1.  Pharmacokinetic data on doxycycline and its distribution in different biological fluids in female goats.

Authors:  V K Jha; C Jayachandran; M K Singh; S D Singh
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

2.  Pharmacokinetics of doxycycline in dogs.

Authors:  R C Wilson; D T Kemp; J V Kitzman; D D Goetsch
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

3.  Some pharmacokinetic parameters of doxycycline in east African goats after intramuscular administration of a long-acting formulation.

Authors:  I M Ole-Mapenay; E S Mitema
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

4.  Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs.

Authors:  E B Breitschwerdt; M G Davidson; B C Hegarty; M G Papich; C B Grindem
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression.

Authors:  Nicole A Vander Schaaf; Shirley Oghamian; Jin-A Park; Liang Kang; Peter W Laird; Kwang-Ho Lee
Journal:  J Vis Exp       Date:  2019-03-29       Impact factor: 1.355

6.  Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma.

Authors:  Kelly R Hume; Skylar R Sylvester; Lucia Borlle; Cheryl E Balkman; Angela L McCleary-Wheeler; Mary Pulvino; Carla Casulo; Jiyong Zhao
Journal:  Front Vet Sci       Date:  2018-02-26

Review 7.  Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.

Authors:  Brandon J Walters; Amber B Azam; Colleen J Gillon; Sheena A Josselyn; Iva B Zovkic
Journal:  Front Genet       Date:  2016-01-12       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.